T he interferon (IFN)-induced transmembrane protein (IFITM) genes consist of a family of genes encoding related proteins: Ifitm1,2,3,5,6,7, and 10 in mice and IFITM1, 2, 3, 5, and 10 in humans (1, 2). The expression of several IFITM genes (e.g., those encoding IFITM1, 2, and 3) can be induced by type I, II, or III IFNs (3, 4). Although initial studies described possible roles of IFITM1, IFITM2, and IFITM3 in development, apoptosis, cell proliferation, and cell signaling (5-13), a subsequent report suggested that ectopic expression of IFITM1 in mouse L cells could restrict infection of vesicular stomatitis virus (VSV) (14). A decade later, gene silencing and ectopic expression studies established that IFITM proteins have antiviral activity in cell culture against members of the Flaviviridae, Orthomyxoviridae, Filoviridae, Rhabdoviridae, Retroviridae, Bunyaviridae, Reoviridae, Togaviridae,. Nonetheless, some enveloped and nonenveloped viruses appear to be resistant to the actions of IFITM proteins, including arenaviruses, papillomaviruses, cytomegaloviruses, and adenoviruses (16,17,29).IFITM proteins are transmembrane proteins. Although their precise membrane topology remains uncertain (5,6,15,(30)(31)(32)(33)(34)(35)(36), recent studies suggest that they are type II membrane proteins (35)(36)(37). Moreover, the cellular sublocalization of the IFITM proteins varies among family members, with IFITM1 expressed primarily at the plasma membrane, and IFITM2 and IFITM3 colocalizing predominantly with late endosomes (20,32). Based on the cellular localization and effects on specific steps in viral life cycles, IFITM1, IFITM2, and IFITM3 appear to restrict fusion and uncoating of viruses into the cytoplasm (33,38,39), with different IFITM proteins inhibiting specific viruses in distinct membrane compartments. Despite the intensive study of the IFITM proteins in cell culture, the precise mechanism of restriction of viral fusion has remained elusive. It has been suggested that IFITM proteins